Clinical trial
Safety of Fecal Microbiota Transplant Using Oral Encapsulated PRIM-DJ2727 in HIV-infected Persons on Antiretroviral Therapy
NCT03329560 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Fecal Microbiota Transplant Using Oral Encapsulated PRIM-DJ2727 in HIV-infected Persons on Antiretroviral Therapy
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 12, 2018
- Completion date
- October 8, 2019
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-1-infection